Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume 19, Issue 2, Pages 735-746Publisher
IOS PRESS
DOI: 10.3233/JAD-2010-1272
Keywords
Acetyl-L-carnitine; Alzheimer's disease; hyperphosphorylation; okadaic acid; spatial memory; tau
Categories
Funding
- Committee of Science and Technology of China [2006CB500703]
- Natural Science Foundation of China [30800342, 30971478]
Ask authors/readers for more resources
Tau hyperphosphorylation and memory deficit are characteristic alterations of Alzheimer's disease (AD). Protein phosphatases (PP) 2A plays a crucial role in AD-like lesions. Inhibition of PP2A through hippocampal injection of okadaic acid (OA) induces tau hyperphosphorylation and memory impairment of rats. By using this model, we explored in the present study the effects of acetyl-L-carnitine (ALCAR), a constituent of the inner mitochondrial membrane, on the memory retention, tau phosphorylation, and oxidative stress in rats. We found that pre-treatment of ALCAR(50 mg/d.rat, per os) for two weeks efficiently improved the OA-induced spatial memory retention impairment of the rats. ALCAR antagonized tau hyperphosphorylation at multiple AD sites and it abated the OA-induced PP2A inhibition and oxidative stress. Our study provides the first in vivo evidence that ALCAR can attenuate AD-like PP2A inhibition, tau hyperphosphorylation, and spatial memory deficit of the rats. It suggests that ALCAR may hold potential in AD treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available